drugset / Trial / NCT07535970
A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants
NaSingle-groupOpen-labelTreatment
Summary
A single-center, open-label, fixed-sequence, self-controlled phase I clinical trial aimed at evaluating the effect of itraconazole capsules(CYP3A inhibitor) on the pharmacokinetics of HS-10506 tablets in healthy participants.
Timeline
- Start
- 2026-04-30
- Primary completion
- 2026-07-30
- Completion
- 2026-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10506 | Unknown | — | Oral |
| Subject | Itraconazole | Small molecule | 0.2 g | Oral |
Indications
No indication recorded.